We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
58 hedge funds and large institutions have $46M invested in CASI Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.57% less ownership
Funds ownership: 3.34% → 2.77% (-0.57%)
15% less funds holding
Funds holding: 68 → 58 (-10)
28% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 18
36% less capital invested
Capital invested by funds: $72.3M → $46M (-$26.3M)
50% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 20
Holders
58
Holders Change
-10
Holders Change %
-14.71%
% of All Funds
1.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
13
Reduced
18
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$11.8M |
| 2 |
Charles Schwab
San Francisco,
California
|
-$475K |
| 3 |
Millennium Management
New York
|
-$403K |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$335K |
| 5 |
JP Morgan Chase
New York
|
-$249K |
